Skip to main content
OpenTrials
Completed

NCT Number: NCT03800927

Long-Duration Ultrasound for Knee Osteoarthritis

This study will measure the 24-week pain relief from long-duration ultrasound on the symptoms of knee arthritis pain.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Orthopedic Foundation, Stamford, Connecticut, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Are you between 18 and 80 years of age (inclusive)?
  • Can you speak, read, and write in English?
  • Do you have knee pain that has lasted at least 3 months?
  • Are you willing and able to self-administer the ultrasound device daily within your place of residence or during normal daily activity?
  • Are you willing to keep all pain medications stable and discuss with the investigator any needs to change medications during the study period? This may include drugs administered topically, orally, transdermally, or by injection.
  • Are you willing to document usage of any medications during the study period?
  • Do you agree to discontinue all other interventional treatment modalities on the lower back during the study? (e.g., transcutaneous electric nerve stimulation [TENS], electronic muscle stimulation, traditional ultrasound, massage therapy, chiropractic services)
  • On a Numeric Rating Scale (NRS) of 0 (no pain) to 10 (pain as bad as you can imagine), how would you rate your average pain over the past week? Pain must be ≥4 for the subject to be enrolled in this study. This criterion will be assessed by self-report at Visit 1.

Exclusion criteria

  • Have you participated in a clinical trial for an investigational drug and/or agent within 30 days prior to screening?
  • Are you pregnant?
  • Are you a prisoner?
  • Are you non-ambulatory (unable to walk)?
  • Do you have a pacemaker?
  • Do you have a malignancy in the treatment area?
  • Do you have an active infection, open sores, or wounds in the treatment area?
  • Do you have impaired sensation in the treatment area, such as caused by chemotherapy or anesthesia?
  • Do you have a known neuropathy (disease of the brain or spinal nerves)?
  • Do you have a hereditary disposition (tendency) for excessive bleeding (hemorrhage)?
  • Do you have peripheral artery disease?
  • Does the subject display any condition which, in the judgment of the investigator, would make participation in the study unacceptable including, but not limited to, the subject's ability to understand and follow instructions?

Treatment and study plan

Long duration ultrasound

Device

Low-intensity long duration ultrasound treatment

Primary outcomes

  1. Change in Pain Units on a Numeric Rating Scale (NRS)

    Time frame: Average of first week (start of study) to average measure at 24 weeks (end of study)

    NRS on the scale of 1 - 10, 1 being minimum and 10 being maximum, Change was calculate from base line

Secondary outcomes

  1. Function

    Time frame: First week (start of study) to 24 weeks (end of study)

    WOMAC questionnaire will be utilized (Western Ontario and McMaster Universities Arthritis Index) at baseline and post-treatment to calculate the change in the scores. WOMAC was divided into 3 categories: pain, stiffness, function and total score. The pain category consists of five scores from 0-10, 0 is no pain 10 is worst pain possible for a range of 0 - 50 points. The stiffness category consists of two scores from 0-10, 0 is no stiffness 10 is worst stiffness possible for a range of 0 - 20 points. The function score consists of 17 scores from 0-10, 0 is normal function and 10 is severely limited function, for a range of 0 - 170 points. Categories were multiplied by 10 for analysis. Total score is the sum of pain, stiffness, and function scores (range of 0 - 2400)

  2. Strengthen

    Time frame: First week (start of study) to 24 weeks (end of study)

    Strength measurement with force meter (Newtons)

  3. Range of motion

    Time frame: First week (start of study) to 24 weeks (end of study)

    Range of Motion measurement with motion machine (Degrees)

Sponsors and collaborators

Lead sponsor

ZetrOZ, Inc.

Industry

Registry information

Official study title

Multi Week Long-Duration Ultrasound for Knee Osteoarthritis

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Jan 11, 2019
Registry last updated
Jun 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.